GKT-137831
-
Technical Data
Description
GKT-137831 is a novel and potent Nox4 inhibitor. GKT-137831 reduced the increased leukocyte adherence to the vasculature, the pro-inflammatory phenotype of microglia and macroglia, the increased gene and protein expression of vascular endothelial growth factor, monocyte chemoattractant protein-1, and leukocyte adhesion molecules as well as vascular leakage. In all cultured cell types, GKT-137831 reduced the hypoxia-induced increase in ROS levels and protein expression of various inflammatory mediators. GKT-137831 may be potentially useful as a treatment for a variety of vision-threatening retinopathies.
Related products
ABT-263 (Navitoclax)
from $50.00
MEK-162 (ARRY-162)
from $60.00
E-7090
from $280.00
E-7080 (Lenvatinib Mesylate)
from $80.00